Subcutaneous infliximab biosimilar approved in the E.U. for the treatment of RA Nov. 28, 2019 No Comments
FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease Nov. 18, 2019 No Comments
European Commission grants conditional marketing authorization to Ebola Zaire vaccine Ervebo Nov. 12, 2019 No Comments
FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions Nov. 11, 2019 No Comments
RSS